Study of the Relationship between Angiogenic Factors and Mechanism of Preeclampsia
LI Huabing
Abstract
LI Huabing
Abstract
Objective:To study the relationship between serum soluble intercellular adhesion molecule-1(sICAM-1) and vascular endothelial growth factor(VEGF), placenta growth factor(PLGF), vascular endothelial growth factor receptor 1(VEG- FR1, Flt-1), soluble vascular endothelial growth factor receptor 1 (sVEGFR1, sFlt-1) mRNA expression in placenta tissue of preeclampsia (PE). Methods: The serum level of sICAM-1 was measured by enzyme-linked immunosorbent assay and gene expression of placenta tissue was detected by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Re- sults:(1)The average serum level of sICAM-1 was(218.45±29.93) μg/L in PE group compared with (168.84±19.39) μg/L in controls (P 0.01).(2)The mRNA expressions of VEGF, PLGF, Flt-1 and sFlt-1 were increased in placenta of PE than those in controls (P 0.01).(3)There was a positive correlation between the serum level of sICAM-1 and the sFlt-1 mRNA expres- sion in placenta tissue (r = 0.90, P 0.01). Conclusion: The serum level of sICAM was increased in the patients with PE. The expressions of VEGF, PLGF, Flt-1 and sFlt-1mRNA were increased remarkably in the placenta tissue of palients with PE,es- pecial for sFlt-1. The remarkable increase for expression of sFlt-1mRNA may contribute to endothelial dysfunction, hyperten- sion and proteinuria.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the relationship between serum soluble intercellular adhesion molecule-1(sICAM-1) and vascular endothelial growth factor(VEGF), placenta growth factor(PLGF), vascular endothelial growth factor receptor 1(VEG- FR1, Flt-1), soluble vascular endothelial growth factor receptor 1 (sVEGFR1, sFlt-1) mRNA expression in placenta tissue of preeclampsia (PE). Methods: The serum level of sICAM-1 was measured by enzyme-linked immunosorbent assay and gene expression of placenta tissue was detected by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Re- sults:(1)The average serum level of sICAM-1 was(218.45±29.93) μg/L in PE group compared with (168.84±19.39) μg/L in controls (P 0.01).(2)The mRNA expressions of VEGF, PLGF, Flt-1 and sFlt-1 were increased in placenta of PE than those in controls (P 0.01).(3)There was a positive correlation between the serum level of sICAM-1 and the sFlt-1 mRNA expres- sion in placenta tissue (r = 0.90, P 0.01). Conclusion: The serum level of sICAM was increased in the patients with PE. The expressions of VEGF, PLGF, Flt-1 and sFlt-1mRNA were increased remarkably in the placenta tissue of palients with PE,es- pecial for sFlt-1. The remarkable increase for expression of sFlt-1mRNA may contribute to endothelial dysfunction, hyperten- sion and proteinuria.
Key concepts: Placenta, Vascular endothelial growth factor, Preeclampsia, Placental growth factor, Internal medicine, Endocrinology, Receptor, Andrology